Hulda Swai
Hulda Shaidi Swai is a Tanzanian researcher and professor in life sciences and bioengineering known for her work in nanomedicine.

Hulda Shaidi Swai is a Tanzanian researcher and professor in life sciences and bioengineering. She is a pioneer in nanomedicine research for developing drugs against infectious diseases in Africa. Her work focuses on using nanotechnology in antimalarial drugs.
Born in 1954 in Vudee village, Same District, Kilimanjaro, Swai attended secondary schools in the 1970s. She graduated from the University of Dar es Salaam in 1980 with degrees in chemistry and statistics.
Swai earned a Master of Science in chemical engineering from Queen Mary University of London in 1985. She obtained a PhD in biomaterials from the same university in 2000. She worked as a researcher at Queen Mary University of London for nine years.
From 2001 to 2014, Swai was a researcher at the Council for Scientific and Industrial Research (CSIR) in South Africa. She heads the Department of Science and Technology / Pan-African Center of Excellence for Research and Training in Applied Nanomedicine. In 2009, she joined the Developing Countries Coordinating Committee of the European Developing Countries Clinical Trials Partnership (EDCTP).
In 2011, Swai organized the first international workshop on nanomedicine for diseases of poverty in South Africa. She was appointed an extraordinary professor at the University of Pretoria in 2013. In 2015, she returned to Tanzania to join the Nelson Mandela African Institution of Science and Technology (NM-AIST) as a professor.
At NM-AIST, she led the bid for a World Bank-funded African Center of Excellence (ACE II project). In December 2016, NM-AIST was chosen to host two African Centers of Excellence. Swai became responsible for the African Center for Research, Agricultural Progress, Excellence in Education and Sustainability (CREATES).
The Malaria Project at CREATES launched in 2016 and received US$6 million from the World Health Organization. This pilot project aims to prove the potential of nanomedicine in diagnostics and disease treatment. Swai's research on nanomedicine for tuberculosis and malaria drugs is in preclinical development.
In 2019, Swai became president of the African Materials Research Society (AMRS). In 2020, she became the holder of the Oliver Tambo Chair in nanotechnology regarding biomedical health and sustainable agriculture. She also received the 2020 African Union Kwame Nkrumah Award for Scientific Excellence.
Key facts
- Hulda Shaidi Swai is a professor in life sciences and bioengineering.
- She specializes in using nanotechnology for antimalarial drugs and tuberculosis treatments.
- She is the head of the African Center for Research, Agricultural Progress, Excellence in Education and Sustainability (CREATES).
- She received the 2020 African Union Kwame Nkrumah Award for Scientific Excellence.